Abstract
Introduction
Coronary heart disease is expected to become the leading worldwide cause of death by 2020 [1] ; acute myocardial infarction is a major cause of such mortality. In patients with acute myocardial infarction, rapid restoration of blood flow (reperfusion) is the most effective treatment for myocardial salvage, either by thrombolysis or primary percutaneous coronary intervention. However, it is now clear that reperfusion has the potential to induce additional lethal injuries that are not present at the end of the ischaemic period [2, 3] . [5] [6] [7] [8] [9] [10] [11] [12] . For instance, Hori and colleagues [7] tested the hypothesis that post-ischaemic stunning could be favourably attenuated if perfusion pressure upon initial relief of ischaemia was increased slowly as opposed to abruptly. Indeed, fractional shortening at 3 hrs postreperfusion was significantly improved in hearts that received gradual reperfusion versus controls [7] . Similarly, in a canine model of coronary bypass, Okamoto et al. [5] initiated reperfusion either abruptly with full systemic pressure, or at a low pressure (50 mmHg) for 20 min. before full systemic pressure was restored. Interestingly, initial low-pressure reperfusion was associated with smaller infarct size and improved recovery of regional contractile function [5] . In the 1997 it has been reported that the gradual reperfusion limited the necrosis which followed ischaemia/reperfusion, but was accompanied by an increased leukocyte adherence to the endothelium [10] . The authors of this study suggested that the means by which reperfusion is initiated may play an important role in determining cardiomyocytes survival and, ultimately, clinical outcome. Notably, the concept of gentle or graded reperfusion has not been limited to the heart, and has also been found to be beneficial in other organs [11] . Despite the aforementioned experimental data suggesting that low-pressure reperfusion can limit myocardial ischaemia/reperfusion injury, this strategy has received limited clinical and experimental attention. The reasons of which could be: (1) clinicians are resistant to in induce a marked lowering of blood pressure immediately after restoring coronary patency in the cardiac catheterization laboratory, which could prove to be particularly harmful in patients who are already haemodynamically unstable due to myocardial ischaemia, (2) an adequate training of emergency medical professionals to provide timely intervention is required, (3) graded reperfusion would be difficult to implement safely outside of the controlled conditions of bypass surgery, (4) despite infarct size reduction with graded reperfusion an increase in leukocyte adhesion has been reported [10] , and last, but not least (5) most of the aforementioned experimental data were obtained in a historic period in which preconditioning mechanisms were little or not know at all.
During late 1980s researchers had already started to investigate whether or not pharmacologically modified reperfusates could reduce reperfusion injury [for review see 4]. Moreover, several studies have examined whether myocardial damage by ischaemia /reperfusion could be limited if reperfusion was initiated in a gentle (low pressure) manner as opposed to standard full flow (high pressure)
Beginning with the knowledge on gradual reperfusion and preconditioning, a few years ago, Vinten-Johansen group [13] see 4] . Therefore [14] [15] [16] [17] .
introduced the ischaemic Postconditioning (PostC) treatment against ischaemia/reperfusion injury. As ischaemic preconditioning, ischaemic PostC consists of brief periods of ischaemia reperfusion. PostC, in fact, consists of brief periods of reperfusions alternating with brief re-occlusion applied during the very early minutes of a reperfusion. Emerging data are now showing that the mechanical interventions of ischaemic PostC may activate multiple and interacting components which can protect the heart against myocardial injury. It seems that part of the protective effects are due to fact that an abrupt reperfusion is avoided and part to the fact that intermittent reperfusion may elicit endogenous cardioprotective mechanisms, which can protect against the numerous series of mechanisms contributing to reperfusion injury (see below). Notably PostC reduces post-ischaemic leukocyte adhesion in the heart. Besides these mechanical interventions (gradual reperfusion and PostC), several pharmacological interventions have been studied against reperfusion injury (see below). For instance, it has been reported that either hypoxic reperfusion or reperfusion at lower pH at the onset of reperfusion could reduce reperfusion injury by lowering the formation of reactive oxygen species (ROS) [for review
Since IP triggers protective pathways before ischaemia, whereas PostC alters events after ischaemia, it has been hypothesized that the mechanisms by which preconditioning and PostC confer myocardial protection should be different [13, 18] . There is no doubt that triggering the preconditioned state prior to ischaemia may activate a "memory function" that results in a modification of heart phenotype which may include a prolonged activation of the adenosine signal and of kinases at reperfusion [19] . Yet [14] [15] [16] [17] [20] [21] [22] [23] [24] [25] . Pre-and PostC also reduce the oxidant-induced injury; moreover, they attenuate the local inflammatory response to reperfusion [13, [26] [27] [28] [29] [30] The pathogenesis of reperfusion injury has been reviewed elsewhere [3, [37] [38] [39] 
Causes of reperfusion injury

Effects of reperfusion injury
Among the outcomes of reperfusion injury are included: (1) 
Definition of postconditioning
The concept of 'Ischaemic PostC' was first described by Vinten-Johansen's group [13] [28] . Accordingly, in the present review we will use the term 'PostC algorithm' to refer to PostC procedure/protocol. In virtually in all of the species in which different PostC algorithms have been tested they have been protective, including humans, with the exception of a recent work conducted on a rodent model [65] (Table 2 ). However, many other groups observed a cardioprotective effect of PostC in rodent models [27] , including mice lacking connexin 43 [66] . With respect to this, it is paradigmatic the porcine model. In fact, in swine there are two studies: in one study, Schwarz & Lagranha [67] (60-90 sec) [28, 70, 71] .
Postconditioning algorithm
PostC can be obtained by different protocols in terms of duration of the periods of reperfusion and ischaemia and/or in terms of number of cycles of I/R applied after an infarcting ischaemia. These different procedures/protocols have been called PostC algorithms by Vinten-Johansen
In the rat hearts we compared a 'classical' PostC algorithm which consisted of five cycles of 10 sec. reperfusion and occlusion with a 'modified' algorithm of PostC (Fig. 1) (20, 25 and 30 sec.) . This modified PostC protocol was equally effective as the classical algorithm in reducing the infarct size [72, 73] .
Importantly, in all species, the PostC stimulus must be applied immediately upon relief of sustained ischaemia to be protective: if initial complete reperfusion is allowed to continue for more than the first 60-90 sec., then protection against infarct size extension is lost [27, 32, 74] .
Protective effects of postconditioning
Depending on species, models and other factors, PostC reduces infarct size by ~20-70% versus matched controls with matched risk areas. There is an emerging agreement across multiple models and species that PostC may reduce endothelial dysfunction and endothelial activation, thus leading to a reduced endothelia/leukocyte interaction and to a reduced ROS formation. It has been also observed a reduced incidence of apoptosis and arrhythmias. Whether PostC reduces post-ischaemic stunning it
has not yet been clarified.
Infarct size reduction
In their seminal study Vinten-Johansen and coworkers [13] 75, 76] (Table 2) . As said, in multiple species and models, PostC reduces infarct size by ~20-70% versus matched controls with matched risk areas [13, 34] . Studies from our laboratory and other laboratories confirmed the infarct size reduction in rat isolated heart model [20, 35, 72, 73, 76, 77] . We showed that in hearts perfused with constant flow the infarct size reduction by PostC is greater than that observed in the same model perfused at constant pressure [73] (see also below).
Reduction of apoptosis
Apoptosis is a genetically programmed cell death that occurs in reperfusion injury [41, [78] [79] [80] 
Reduction in endothelial dysfunction
The endothelial cell dysfunction is a common characteristic of various heart pathologies [82, 83] . In their seminal study Zhao et al. [13] 
Reduction in endothelial activation, and neutrophil adherence
PostC decreases the expression of P-selectin, an adhesion molecule, on the surface of endothelial cells. Moreover it has been observed both a reduction in neutrophils adhesion on the post-conditioned
Reduction of stunning
The studies which tested whether PostC may improve post-ischaemic myocardial function after a postinfarcting ischaemia report either an improvement [13, 21, 34] [86] . In an ex vivo preparation of human atrial appendages hypoxic PostC seems to attenuate post-ischaemic dysfunction [21] . [84] showed that the combination of protocols is not additive for infarct size reduction, anion production nor for post-ischaemic endothelia dysfunction. Similar results were obtained by Tsang et al. [20] and by us [73] [94] .
Anti-arrhythmic effects
Remote postconditioning
As stated, preconditioning can be obtained with ischaemias of distant organs (remote preconditioning) [95, 96] . Remote preconditioning of the heart was introduced by Przyklenk et al. [95] [96] . Recently, it has been reported that remote ischaemic PostC can protect the heart against acute myocardial infarction in pigs, rabbits and rats. [14, 35, 36, 97] [98] .
, which observed that preconditioning ischaemia on one coronary artery territory can protect the non-treated myocardial territory (virgin myocardium) against a subsequent infarcting ischaemia. Later on, several studies indicated that a brief ischaemic insult on one organ releases endogenous factors that protect other organs against a prolonged ischaemic insult. This phenomenon, was termed remote preconditioning or preconditioning at a distance, and implicates an endocrine action, and/or neural-humoural signalling
Remote ischaemic PostC was induced by cycles of few minutes of I/R applied to a distal artery territory (femoral or renal artery) either immediately after the beginning of heart reperfusion (Pig) or just few minutes before heart reperfusion (Rabbits and Rats)
. Very recently, it has been shown that remote PostC induced by transient limb ischaemia can prevent endothelial I/R injury in humans
Pharmacological postconditioning
Several studies have demonstrated that many drugs including adenosine, adipocytokines, erythropoietin, bradykinin, genistein, insulin, natriuretic peptides, statins and volatile anaesthetics when administered at the time of reperfusion, reduce myocardial infarct size through the activation of the so called RISK pathway [14, 22, 23, 99] . Ultimately, this recruits various pathways that lead to the inhibition of mPTP opening [15, 23, 100, 101] . In fact Ciclosporin A, a mPTP blocker, can also be used at the time of myocardial reperfusion as pharmacological mimetic of PostC [101] (See also below 'Active mechanisms').
We recently introduced a sort of staccato treatment with either bradykinin (BK) or diazoxide to mimic ischaemic PostC [33]. In this study we were able to trigger the protective effect of PostC against infarct size using the drugs for few seconds at the beginning of reperfusion. We mimicked PostC with five cycles of 10 sec. drug infusion alternated with 10 sec. of simple reperfusion, exactly as ischaemic PostC is obtained alternating for a few seconds ischaemia and reperfusion. The downstream pathway activated by intermittent BK seems very similar to that activated by ischaemic PostC. This is a completely novel way to use the drugs during reperfusion. It is worthy for future experiments to test if other drugs can trigger PostC-like protection in this way. We have tried to reproduce these results using intermittent adenosine in lieu of BK. Unfortunately, intermittent adenosine was not as effective as intermittent BK [unpublished observations]. Overall these results teach us that not only the mechanism of action of the drug, but also timing and mode of infusion are very important in reperfusion.
Postconditioning the human heart
Ischaemic PostC has been shown to potentially reduce myocardial injury in patients undergoing primary coronary angioplasty for an acute myocardial infarction. In some studies PostC with stuttered 60 sec or 90 I/R appears to be protective [70, 71] [102] . Moreover, very recently, Sivaraman et al. [21] reported
Importantly, the results of above studies are confirmed in a retrospective study, in which it is reported that multiple balloon inflations during primary angioplasty may confer cardioprotection similarly to PostC
that in an ex vivo preparation, hypoxic PostC protects human atrial appendages against postischaemic dysfunction, and that this effect is dependent on the activation of the RISK pathway. This pathway, as mentioned above, plays a pivotal role in PostC protection as we will see in the following sections.
Postconditioning in diseased hearts
Many studies have suggested that certain diseases (e.g. hypertrophy, remodelling, heart failure, atherosclerosis, diabetic disorder) and also age might negatively impact the endogenous protective mechanisms of preconditioning [16] . To the best of our knowledge, so far, few studies analysed the role of diseases in PostC cardioprotection [103] [104] [105] [106] . In particular, two studies from different laboratories suggested that in the presence of metabolic syndrome, the heart may be more resistant to PostC protection and that a stronger stimulus may be necessary to reduce infarct size [105, 106] . Yet, PostC has been shown to be able to attenuate I/R injury in both hypertrophied and remodelled heart [103, 104] . Interestingly, in the human study by Staat et al. [71] [14, 17, [22] [23] [24] 107] . Delayed washout of endogenously produced adenosine and activation of the adenosine receptor also seems required for PostC protection, [77] [77] have been seen to be involved, in rabbit hearts PostC seems to depend on A2b subtype [74] . An important role of the redox environment has been also observed [33, 76] .
Mechanisms involved in postconditioning
Active mechanisms (intramyocardiocyte mechanisms)
What are the intracellular mechanisms of the protection? Studies have identified a signalling pathway that is recruited at the time of reperfusion and which is similar in ischaemic preconditioning and PostC. This pathway includes the survival kinases phosphatidylinositol 3-kinase (PI3K)-Akt and Erk1/2, the major components of the reperfusion-injury salvagekinase pathway, termed the RISK-pathway, which may influence the mPTP, a non-specific pore of the mitochondrial membrane whose opening in the first few minutes of myocardial reperfusion promotes cell death
Therefore, similar to preconditioning, PostC has been proposed to be triggered by receptor stimulation, mediated by one or more complex and interrelated signal transduction pathways, and, ultimately, achieved via phosphorylation of one or more endeffectors of cardioprotection [17, 24] .
Triggers
Ligands, such as adenosine [74, 77] [109] .
Among the autacoids released by the ischaemic heart there is BK which may induce nitric oxide release (Fig. 3) . It has been suggested that the mechanism whereby NO protects myocardium includes the activation of guanylate-cyclase [110] . As an inducer of the protection, nitric oxide may also directly open the mitochondrial KATP channels [111] . Therefore, nitric oxide acting on mitochondria may play a relevant role in protection both through activation of these channels and via modulation of respiratory chain; both mechanisms favor ROS signalling, which can trigger protection [112, 113] . A relevant role of nitric oxide may also be attributed to the endothelial protection brought about by this molecule [114] [115] or to its role as antioxidant under certain conditions [116, 117] .
The [57] and Schulz et al. in 2004 [124] .
ROS could also be included among the triggers of PostC. In fact, ROS scavengers such as N-acetylcysteine and 2-mercaptopropionylglycine given during PostC manoeuvres prevent the protective effects [33, 76, 125, 126] . It is possible that the low pH during the PostC cycles prevents mPTP opening, while the intermittent oxygen bursts allow mitochondria to [100, 127] . Acidosis may also prevent mPTP opening in the early reperfusion (see below).
Recently, it has been reported that redox signalling and a low pH at the time of myocardial reperfusion are also required to mediate the cardioprotection triggered by ischaemic preconditioning [128] .
Mediators
We [72, 73] . Moreover we showed that in these hearts mKATP and PKC must be also active (i.e. they should not be blocked) during late reperfusion [76] . Regarding the role of mKATP channels a couple of papers indicate that the mKATP channel are important for PostC [34, 76] . In such studies two different mKATP channel blockers (glibenclamide and 5-hydroxydecanoate) abolished the protective effect of PostC [34, 76] . [17, 20, 24, 25, 28, 34] . Some differences, however, may exist between pre-and PostC (see also [10, 48, 57-59, 64-68, 76, 125, 136, 138, 139, 144-147] 
It is interesting that many of the RISK elements (e.g. PI3K/Akt and MEK1/2-ERK) involved in the signalling pathway in preconditioning protection against reperfusion injury have recently been documented also in PostC
